All from 2024 All from 2023 All from 2022 All from 2021 All from 2020 All from 2019 All from 2018 All from 2017 All from 2016 All from 2015 All from 2014 All from 2013 All from 2012 All from 2011 All from 2010 All from 2009

Delete filters

Clínic Barcelona

Institutional September 22 2022

The Hospital Clínic starts an immunotherapy trial based on tumour-infiltrating lymphocytes (TILs) in triple-negative breast cancer

Trial TILs001, which is open to patients with metastatic triple-negative breast cancer, is the first study to assess the safety and efficacy of TILs1

News about TILs

The Hospital Clínic starts an immunotherapy trial based on tumour-infiltrating lymphocytes (TILs) in triple-negative breast cancer

Subscribe to the Newsletter of Clínic